PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
261 hedge funds and large institutions have $4.79B invested in PRA Health Sciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 122 increasing their positions, 69 reducing their positions, and 15 closing their positions.
200% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 15
77% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 69
21% more call options, than puts
Call options by funds: $7.62M | Put options by funds: $6.29M
11% more funds holding
Funds holding: 236 → 261 (+25)
3% more capital invested
Capital invested by funds: $4.66B → $4.79B (+$129M)
0.88% more ownership
Funds ownership: 99.58% → 100.45% (+0.88%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$76.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.5M |
| 3 |
Millennium Management
New York
|
+$63.3M |
| 4 |
BlackRock
New York
|
+$58.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$718M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$18.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$12.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$11.1M |
PRAH Hedge Fund Activity: Q3 2017 in Review
261 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2017, worth a combined $4.79B — up 2.8% from $4.66B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new PRAH positions and 15 closed out — a net gain of 30 holders — while 122 added to existing stakes and 69 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $76.1M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $718M.
- 261 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q3 2017, up from 236 in Q2 2017.
- Funds reported $4.79B of PRA Health Sciences, Inc. stock for Q3 2017, up 2.8% quarter-over-quarter.
- 45 funds opened new PRA Health Sciences, Inc. positions in Q3 2017 and 15 closed out, a net change of +30 holders.
- The largest PRA Health Sciences, Inc. buyer in Q3 2017 was Fidelity Investments, an estimated $76.1M added.
- The largest PRA Health Sciences, Inc. seller in Q3 2017 was Kohlberg Kravis Roberts & Co, an estimated $718M sold.
Based on aggregated 13F filings for Q3 2017.